All Type of News
Government mulls re-categorizing drugs
The Ministry of Health and Welfare is considering allowing allow convenience stores to sell some medicines that are currently only sold in pharmacies.
“We will hold a series of meetings from June 15 to review the c...
Battle gets fiercer over OTC market
Domestic pharmaceutical firms have waged fiercer campaigns to raise their over-the-counter (OTC) market share amid stronger competition.
Daewoong Pharmaceutical’s Ursa advertisement using Korea’s football player Ch...
Gilead Sciences names new Korean CEO
Lee Seung-woo, director of AIESEC Association Korea, has been elected as the new president of Gilead Sciences Korea.
The incoming president has served as CEO of multinational pharmaceutical companies, including MS...
Health ministry to face backlash
Despite its promise to come up with detailed measures for sales of OTC drugs at supermarkets at the end of May, the Ministry of Health and Welfare scrapped the plan suddenly last week, allegedly due to a strong opposi...
Concerns mount over OTC switching system
The planned OTC switching plan of prescriptions is some of the concerns that make Korean drug companies feel uncomfortable, market watchers said.
Many say the plan could result in great setbacks for their revenues ...
Central Pharmaceutical Affairs Review Committee to implement drug reclassification plan
The Ministry of Health and Welfare said that the Central Pharmaceutical Affairs Review Committee, which is under the umbrella of the Korea Food and Drug Administration, will be mainly responsible for pushing up with a...
Government to readjust drug dispensing fee from July
The Ministry of Health and Welfare said Friday that the drug dispensing/management fee at pharmacy will be readjusted to a realistic level from July 1.
Under the planned cut of the dispensing/management fee, offici...
Kanarb sales at brisk pace
Boryung Pharmaceutical, one of Korea’s leading drug makers, is enjoying brisk sales of its new antihypertensive drug, Kanarb.
Sales of Dong-A’s antihypertensive agent recorded over 1.3 billion won since its releas...
Supermarket sales of OTC drugs are unlikely
Despite growing calls for sales of OTC drugs at supermarkets and other retail outlets, the government will not allow supermarkets to sell OTC medicines due to safety reasons.
The health ministry will announce today...
Lyrica is reimbursable from this month
From June 1, Pfizer’s Lyrica (pregabalin) could be reimbursed by health insurance, as an adjunct therapy for neuropathic pain and partial seizures with or without secondary generalization in cancer patients.
Lyrica...
